Treatment of restless legs syndrome/Willis-Ekbom disease with selenium
نویسندگان
چکیده
Restless legs syndrome/Willis-Ekbom disease (RLS/WED) is a chronic neurosensory disorder that is characterized by a strong urge to move, accompanied by an uncomfortable paresthesia in the legs which affects about 5-15 percent of adult people in industrialized countries.1 RLS/WED is a puzzling disease, mostly because of the uncertainty of its etiology. There seems to be a genetic component, but it is also known that RLS/WED may be caused by other underlying pathologies and is treated by remedying those conditions. Another highly researched area in the quest to find an etiology and treatment for RLS/WED is the brain dopamine system; in fact, dopaminergic medication is considered the first line of treatment for RLS/WED that is not caused by other underlying factors.1 There is growing evidence, suggesting that selenium plays an important role in many body functions, and seems to be an important regulator of brain function as well.2 Selenium has a strong anti-oxidant action.2 The body concentration of selenium is related to soil concentration, which is low in Sweden. We report the successful treatment of 3 patients with severe RLS/WED with the intake of selenium for 6 months; Three female patients, aged 25-60 years, were all suffering from severe to very severe RLS/WED since childhood. Severity was measured by using the International Restless Legs Scale (IRLS), a 10-item questionnaire developed by the International Restless Legs Syndrome Study Group (IRLSSG).1 Each question has five response options, ranging from “0” to “4”. Hence, the total score can range from “0” to “40”, indicating “no symptoms” to “very severe symptoms”, respectively. The subjects’ IRLS scores were between 25 and 38. The subject with the IRLS score of 25 was being treated with the dopaminergic drug pramipexole, 0.18 mg in the evening. No one was a smoker, and they were healthy and without any other medical treatment or alternative medicine. Height, weight, blood pressure, hemoglobin, the vitamins folic acid and B12, kidney functions and iron status were within normal limits. All 3 patients started to take selenium yeast 100 micrograms daily. This was bought over-theIranian Journal of Neurology
منابع مشابه
Further thoughts on “The Restless Legs Syndrome: Would You Like that with Movements or Without?”: Summary of Evidence that the Presence of Periodic Limb Movements in Sleep Does Not Significantly Aid in the Diagnosis of Restless Legs Syndrome/Willis–Ekbom Disease
In Response to: Koo BB. The restless legs syndrome: Would you like that with movements or without? Tremor Other Hyperkinet Mov. 2015; 5. doi: 10.7916/D80P0Z0H.
متن کاملTreatment Options for Idiopathic Restless Legs Syndrome
The emergence of new effective therapies for idiopathic restless legs syndrome (iRLS) or Willis–Ekbom disease (WED) during the last 15 years resulted in an exponential increase of reports regarding this syndrome and, especially, treatment options. In this review, we summarise the main findings related to neuropharmacological aspects and non-pharmacological therapies of idiopathic RLS (iRLS). As...
متن کاملRestless Legs Syndrome (Willis-Ekbom Disease) and Gastrointestinal Diseases
Over 50 diseases, disorders and conditions have been reported to be associated and/or contribute to restless legs syndrome (RLS) (recently renamed Willis-Ekbom disease). In many of these diseases, disorders and conditions is the potential to have systemic inflammation or immune disorders. In addition, in some of the idiopathic syndromes and diseases, there is an underlying gut dysfunction with ...
متن کاملMedical devices for restless legs syndrome - clinical utility of the Relaxis pad.
Restless Legs Syndrome or Willis-Ekbom Disease, a neurosensory disorder, can be treated with pharmaceuticals or conservatively. This review focuses on conservative treatments, more specifically on treatments with medical devices. Two modes of action, enhancement of circulation and counter stimulation, are introduced. Medical devices that use enhancement of circulation as their mechanism of acti...
متن کاملGuidelines for the first-line treatment of restless legs syndrome/Willis-Ekbom disease, prevention and treatment of dopaminergic augmentation: a combined task force of the IRLSSG, EURLSSG, and the RLS-foundation.
A Task Force was established by the International Restless Legs Syndrome Study Group (IRLSSG) in conjunction with the European Restless Legs Syndrome Study Group (EURLSSG) and the RLS Foundation (RLS-F) to develop evidence-based and consensus-based recommendations for the prevention and treatment of long-term pharmacologic treatment of dopaminergic-induced augmentation in restless legs syndrome...
متن کامل